Literature DB >> 32030505

Soaking of the graft in vancomycin dramatically reduces the incidence of postoperative septic arthritis after anterior cruciate ligament reconstruction.

Philipp Schuster1,2, Michael Schlumberger3,4, Philipp Mayer3, Martin Eichinger3, Markus Geßlein5, Friederike Reddemann5, Jörg Richter3.   

Abstract

PURPOSE: To determine and compare the incidence of postoperative septic arthritis following anterior cruciate ligament reconstruction (ACLR) with and without soaking of the graft in vancomycin solution prior to implantation in a large single-centre case series.
METHODS: From 2004 to 2019, a total of 10,516 primary ACLR were performed and reviewed with regard to the occurrence of postoperative septic arthritis. From February 2017 onwards, all grafts were wrapped in a vancomycin-soaked (5 mg/ml) gauze swab between harvest and implantation (2294 patients, treatment group (2), prospectively followed). These were compared to 8222 patients before that date (control group (1), retrospectively evaluated). The technique of ACLR did not significantly change during the years of the study. There was no difference between the groups with regard to graft choice: Hamstring tendons were used in 99% and quadriceps tendons were used in 1% in both groups, respectively (n.s.). Routine follow-up examination was performed at 6 weeks (follow-up rate 97.1%) postoperatively. Patients with no treatment for septic arthritis at that time were classified as non-infected.
RESULTS: There were 35 cases of postoperative septic arthritis in group 1 (incidence: 0.4%), and none in group 2 (incidence 0.0%), respectively. The difference was significant (p < 0.001).
CONCLUSIONS: Soaking of the graft in vancomycin solution prior to implantation dramatically reduces the incidence of postoperative septic arthritis in primary ACLR and should, therefore, be used in prevention of this major complication. LEVEL OF EVIDENCE: III.

Entities:  

Keywords:  ACL; Anterior cruciate ligament; Antibiotic; Complication; Infection; Local; Presoaking; Septic arthritis; Vancomycin

Year:  2020        PMID: 32030505     DOI: 10.1007/s00167-020-05882-0

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  4 in total

Review 1.  Vancomycin Presoaking of the Graft Appears to Prevent Infection After Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-analysis.

Authors:  Francisco Figueroa; David Figueroa; Rafael Calvo; Alex Vaisman; Marilaura Nuñez; Sven Putnis
Journal:  HSS J       Date:  2021-05-10

2.  Management Guidelines for Infection After ACL Reconstruction: Expert Opinion Statement Based on the Modified Delphi Survey of Indian Arthroscopy Surgeons.

Authors:  I Geethan; Raju Easwaran; Santhosh Sahanand; Arumugam Sivaraman; Arun Gupta; Ashish Devgan; S Ashok; V B Bhasin; Clement Joseph; Deepak Chaudhary; Dinshaw N Pardiwala; P Gopinathan; John Thayyil John; J Maheshwari; Manabendra Nath Basumallick; Nicholas Antao; Nishith Shah; Palanivel Rajan; Parag Sancheti; Paresh Chandra Dey; Prakash Ayyadurai; Prateek Kr Gupta; K Raghuveer Reddy; Ravi Gupta; Ravi Mittal; Sachin Tapasvi; Schiller Thekekara Jos; Skand Sinha; S R Sundararajan; Vinod Kumar; Vivek Pandey; David V Rajan
Journal:  Indian J Orthop       Date:  2021-02-01       Impact factor: 1.251

Review 3.  Vancomycin presoaking of hamstring autografts to prevent infection in anterior cruciate ligament reconstruction: a narrative review.

Authors:  Francisco Figueroa; David Figueroa; Rafael Calvo; Alex Vaisman; João Espregueira-Mendes
Journal:  EFORT Open Rev       Date:  2021-03-01

4.  Presoaking ACL Grafts in Vancomycin Decreases the Frequency of Postoperative Septic Arthritis: A Cohort Study of 29,659 Patients, Systematic Review, and Meta-analysis From the SANTI Study Group.

Authors:  Alessandro Carrozzo; Adnan Saithna; Alexandre Ferreira; Sylvain Guy; Lamine Chadli; Edoardo Monaco; Daniel Pérez-Prieto; Yoann Bohu; Thais Dutra Vieira; Bertrand Sonnery-Cottet
Journal:  Orthop J Sports Med       Date:  2022-02-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.